These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
2065 related items for PubMed ID: 27943261
1. Efavirenz or nevirapine in three-drug combination therapy with two nucleoside or nucleotide-reverse transcriptase inhibitors for initial treatment of HIV infection in antiretroviral-naïve individuals. Mbuagbaw L, Mursleen S, Irlam JH, Spaulding AB, Rutherford GW, Siegfried N. Cochrane Database Syst Rev; 2016 Dec 10; 12(12):CD004246. PubMed ID: 27943261 [Abstract] [Full Text] [Related]
2. Efavirenz or nevirapine in three-drug combination therapy with two nucleoside-reverse transcriptase inhibitors for initial treatment of HIV infection in antiretroviral-naïve individuals. Mbuagbaw LC, Irlam JH, Spaulding A, Rutherford GW, Siegfried N. Cochrane Database Syst Rev; 2010 Dec 08; (12):CD004246. PubMed ID: 21154355 [Abstract] [Full Text] [Related]
3. Tenofovir or zidovudine in three-drug combination therapy with one nucleoside reverse transcriptase inhibitor and one non-nucleoside reverse transcriptase inhibitor for initial treatment of HIV infection in antiretroviral-naïve individuals. Spaulding A, Rutherford GW, Siegfried N. Cochrane Database Syst Rev; 2010 Oct 06; (10):CD008740. PubMed ID: 20927777 [Abstract] [Full Text] [Related]
4. Abacavir-based triple nucleoside regimens for maintenance therapy in patients with HIV. Cruciani M, Mengoli C, Serpelloni G, Parisi SG, Malena M, Bosco O. Cochrane Database Syst Rev; 2013 Jun 05; 2013(6):CD008270. PubMed ID: 23740608 [Abstract] [Full Text] [Related]
5. Optimisation of antiretroviral therapy in HIV-infected children under 3 years of age. Penazzato M, Prendergast AJ, Muhe LM, Tindyebwa D, Abrams E. Cochrane Database Syst Rev; 2014 May 22; 2014(5):CD004772. PubMed ID: 24852077 [Abstract] [Full Text] [Related]
6. Antiretroviral resistance testing in HIV-positive people. Aves T, Tambe J, Siemieniuk RA, Mbuagbaw L. Cochrane Database Syst Rev; 2018 Nov 09; 11(11):CD006495. PubMed ID: 30411789 [Abstract] [Full Text] [Related]
7. Stavudine, lamivudine and nevirapine combination therapy for treatment of HIV infection and AIDS in adults. Siegfried NL, Van Deventer PJ, Mahomed FA, Rutherford GW. Cochrane Database Syst Rev; 2006 Apr 19; 2006(2):CD004535. PubMed ID: 16625606 [Abstract] [Full Text] [Related]
8. Effectiveness of antiretroviral therapy in HIV-infected children under 2 years of age. Penazzato M, Prendergast A, Tierney J, Cotton M, Gibb D. Cochrane Database Syst Rev; 2012 Jul 11; (7):CD004772. PubMed ID: 22786492 [Abstract] [Full Text] [Related]
10. Quality of life in patients treated with first-line antiretroviral therapy containing nevirapine or efavirenz in Uganda: a prospective non-randomized study. Mwesigire DM, Wu AW, Martin F, Katamba A, Seeley J. BMC Health Serv Res; 2015 Jul 28; 15():292. PubMed ID: 26216221 [Abstract] [Full Text] [Related]
11. Outcomes for efavirenz versus nevirapine-containing regimens for treatment of HIV-1 infection: a systematic review and meta-analysis. Pillay P, Ford N, Shubber Z, Ferrand RA. PLoS One; 2013 Jul 28; 8(7):e68995. PubMed ID: 23894391 [Abstract] [Full Text] [Related]
13. Antiretrovirals for reducing the risk of mother-to-child transmission of HIV infection. Siegfried N, van der Merwe L, Brocklehurst P, Sint TT. Cochrane Database Syst Rev; 2011 Jul 06; (7):CD003510. PubMed ID: 21735394 [Abstract] [Full Text] [Related]
14. Stavudine or zidovudine in three-drug combination therapy for initial treatment of HIV infection in antiretroviral-naïve individuals. Spaulding A, Rutherford GW, Siegfried N. Cochrane Database Syst Rev; 2010 Aug 04; (8):CD008651. PubMed ID: 20687097 [Abstract] [Full Text] [Related]
15. Antiretrovirals for reducing the risk of mother-to-child transmission of HIV infection. Volmink J, Siegfried NL, van der Merwe L, Brocklehurst P. Cochrane Database Syst Rev; 2007 Jan 24; (1):CD003510. PubMed ID: 17253490 [Abstract] [Full Text] [Related]
16. Rate of viral load change and adherence of HIV adult patients treated with Efavirenz or Nevirapine antiretroviral regimens at 24 and 48 weeks in Yaoundé, Cameroon: a longitudinal cohort study. Chendi BH, Okomo Assoumou MC, Jacobs GB, Yekwa EL, Lyonga E, Mesembe M, Eyoh A, Ikomey GM. BMC Infect Dis; 2019 Feb 26; 19(1):194. PubMed ID: 30808298 [Abstract] [Full Text] [Related]
17. Antiretroviral therapy (ART) for treating HIV infection in ART-eligible pregnant women. Sturt AS, Dokubo EK, Sint TT. Cochrane Database Syst Rev; 2010 Mar 17; (3):CD008440. PubMed ID: 20238370 [Abstract] [Full Text] [Related]
18. Micronutrient supplementation in adults with HIV infection. Visser ME, Durao S, Sinclair D, Irlam JH, Siegfried N. Cochrane Database Syst Rev; 2017 May 18; 5(5):CD003650. PubMed ID: 28518221 [Abstract] [Full Text] [Related]
19. A combination drug of abacavir-lamivudine-zidovudine (Trizivir) for treating HIV infection and AIDS. Shey M, Kongnyuy EJ, Shang J, Wiysonge CS. Cochrane Database Syst Rev; 2009 Jul 08; (3):CD005481. PubMed ID: 19588374 [Abstract] [Full Text] [Related]
20. Comparative durability of nevirapine versus efavirenz in first-line regimens during the first year of initiating antiretroviral therapy among Swaziland HIV-infected adults. Takuva S, Evans D, Zuma K, Okello V, Louwagie G. Pan Afr Med J; 2013 Jul 08; 15():5. PubMed ID: 23847702 [Abstract] [Full Text] [Related] Page: [Next] [New Search]